Medline (NASDAQ:MDLN) Given Average Recommendation of “Moderate Buy” by Brokerages

Medline (NASDAQ:MDLN) has earned an average recommendation of “Moderate Buy” from the twenty-nine brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twenty-one have issued a buy rating and two have issued a strong buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $50.8462.

A number of equities analysts have weighed in on the company. BTIG Research reissued a “buy” rating and set a $55.00 price target on shares of Medline in a research report on Thursday, May 7th. BNP Paribas Exane cut their price objective on Medline from $49.00 to $40.00 and set a “neutral” rating for the company in a research report on Thursday, May 14th. Sanford C. Bernstein cut their price objective on Medline from $56.00 to $54.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Evercore reaffirmed an “outperform” rating and issued a $55.00 price objective on shares of Medline in a research report on Wednesday, February 25th. Finally, Stifel Nicolaus set a $55.00 price objective on Medline in a research report on Wednesday, February 25th.

Medline Stock Performance

NASDAQ:MDLN opened at $37.10 on Friday. The firm has a 50-day moving average of $42.93. Medline has a 52-week low of $34.89 and a 52-week high of $50.88.

Medline (NASDAQ:MDLN) last released its earnings results on Wednesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.04. The company had revenue of $7.35 billion during the quarter. The business’s quarterly revenue was up 10.7% on a year-over-year basis. On average, analysts anticipate that Medline will post 1.5 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of MDLN. Sound Income Strategies LLC acquired a new position in shares of Medline during the fourth quarter worth $25,000. Entrust Financial LLC acquired a new stake in Medline in the fourth quarter valued at $26,000. NBC Securities Inc. acquired a new stake in Medline during the 4th quarter worth about $28,000. Whipplewood Advisors LLC acquired a new stake in Medline during the 1st quarter worth about $30,000. Finally, Global Retirement Partners LLC acquired a new stake in Medline during the 4th quarter worth about $31,000.

Medline Company Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply?chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.